Quantcast

Latest Subcutaneous emphysema Stories

2008-09-23 03:00:09

Kuros Biosurgery AG and Aeris Therapeutics, Inc., both privately held biotech companies, announced today that Kuros has granted Aeris an exclusive license in the field of lung volume reduction to certain patent rights Kuros exclusively licensed from the American Red Cross that cover the delivery of certain drugs in a fibrin sealant. In return for the license, Kuros will receive upfronts, milestones and royalties on the sale of Aeris' lead product, the AeriSeal(TM) Biologic Lung Volume...

2008-09-03 09:00:07

Aeris Therapeutics, Inc. (www.aerist.com), a company specializing in the development and commercialization of novel treatments for patients with emphysema and other advanced lung diseases, today announced that the primary efficacy endpoint in Phase 2 clinical trials for its Biologic Lung Volume Reduction (BLVR) System has been achieved. BLVR is designed to provide a safe non-surgical alternative to lung volume reduction surgery, one of the few available treatments for patients with advanced...

2008-07-24 00:00:47

Spiration, Inc., a developer of novel medical devices designed to benefit patients with severe and chronic conditions of the lung, announced today that it has signed a definitive agreement giving Olympus Medical Systems Corp. exclusive development and distribution rights in Japan for the IBV(R) Valve System. The IBV Valve System is a minimally invasive treatment that has diverse applications in both acute and chronic conditions of the lung. In Europe, the system has received market...

2007-09-26 09:00:11

Spiration, Inc., a developer of novel medical technology designed to benefit patients with acute and chronic conditions of the lung, today announced that the first patients have been enrolled in the company's IBV Valve Trial in the United States. The purpose of the trial is to generate safety and effectiveness data for submission to the U.S. Food and Drug Administration (FDA) for approval to market the company's IBV Valve System in the United States for the treatment of patients with...

2007-09-19 12:00:10

Spiration, Inc., a developer of novel medical technology designed to benefit patients with acute and chronic conditions of the lung, today reported further results of a pilot study of its IBV Valve System for patients with severe emphysema. Data were presented at the European Respiratory Society's Annual Congress in Stockholm by Daniel Sterman, M.D., director of Interventional Pulmonology at the University of Pennsylvania Medical Center in Philadelphia. "Encouraging results continue...

2007-02-05 15:01:01

Pulmonary and critical care specialists at UC Davis Health System are investigating a new, minimally invasive treatment for those suffering with advanced widespread emphysema. The study is part of an international, multi-center clinical trial involving 12 institutions. Called the EASE(TM) (Exhale(R) Airway Stents for Emphysema) trial, the study focuses on a procedure called airway bypass, which creates ways for air trapped in the lungs to escape, thereby relieving symptoms of emphysema,...

2006-07-10 19:09:50

By Amanda Beck WASHINGTON (Reuters) - Emphysema is less severe in black smokers than in their white counterparts, researchers reported on Monday. This suggests that blacks respond differently to cigarette smoke or that genetic and environmental factors may slightly alter their lung structure, the researchers said. "This data may give us some clues to hone in on how emphysema develops," said Dr. Wissam Chatila, lead author on the study to be published in the journal Chest....

2006-02-03 14:28:51

By Anthony J. Brown, MD NEW YORK (Reuters Health) - A type of operation called lung volume reduction surgery (LVRS) can provide lasting benefits for people with emphysema, including improvements in exercise ability, quality of life, and survival, according to study findings presented at the annual meeting of the Society of Thoracic Surgeons in Chicago. Emphysema, a disease closely associated with smoking, involves the destruction of the tiny air sacs in the lungs where oxygen is...

2005-12-29 10:18:06

By Megan Rauscher NEW YORK (Reuters Health) - Pulmonary rehabilitation produces significant benefits for patients with advanced emphysema and plays an important role in the selection of patients for lung surgery, according to results of the National Emphysema Treatment Trial, or NETT. "The NETT highlights the important benefits of pulmonary rehabilitation -- as practiced in a large number of centers across the country -- as a standard of care for patients with advanced chronic lung...

2004-11-28 03:00:17

Study objectives: Evidence exists that HIV-seropositive individuals may be at increased risk for the development of precocious pulmonary emphysema. HIV infection is also associated with antioxidant deficiency in both the serum and lungs, and it is therefore possible that increased oxidant stress may contribute to parenchymal lung injury occurring in the setting of HIV. We sought to determine the regional distribution of emphysema and regional distribution of glutathione (GSH) concentrations...


Latest Subcutaneous emphysema Reference Libraries

Palpation
2012-11-26 20:39:45

Palpation is a technique used by a physician or medical provider during a physical examination. By placing hands on a patient, data can be gathered that is otherwise unknown by visualization only. What Information it Provides Information such as the temperature of the skin, the moistness or dryness of the skin, the shape of a structure, the location of pain, the radiation of the pain, the quality of function, strength of a structure, amount of swelling, sensation, circulation and so...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'